Bullish & Foolish
Full BMRA fundamentals All 466 on the Survival Watch

BMRABIOMERICA, INC.

Is Biomerica struggling financially?

Yes, by its own account. Biomerica told the SEC on 13 Apr 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed Apr 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$5.0M
Source filing
10-Q 13 Apr 2026
Balance sheet
28 Feb 2026

Cash runway

  • 2months

    If the burn speeds up

    Empty by Apr 2026

  • 4months

    If it eases off

    Empty by Jun 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$1.3M

÷

Cash burned over the last 12 months

$4.7M

What Biomerica told the SEC

…whether we have sufficient liquidity to fund our costs for the next twelve months from each financial statement issuance date to determine if there is a substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern over the next twelve months is influenced by several factors, including: Our need and ability to generate additional revenue from…

BIOMERICA, INC., Form 10-Q, filed 13 Apr 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

Other Biotech/Pharma companies that filed the doubt